Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy R Asmis

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
BMC Cancer|July 7, 2019
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiationShaan Dudani, Horia Marginean, Patricia A Tang, et al.
Cancer Biology & Therapy|July 3, 2010
EGFR expression variance in paired colorectal cancer primary and metastatic tumorsNirit Yarom, Celia Marginean, Terence Moyana, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2008
Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trialsTimothy R Asmis, Keyue Ding, Lesley Seymour, et al.
The Oncologist|March 29, 2014
An open-label phase II study evaluating the safety and efficacy of ramucirumab combined with mFOLFOX-6 as first-line therapy for metastatic colorectal cancerRocio Garcia-Carbonero, Fernando Rivera, Joan Maurel, et al.
Current Oncology (Toronto, Ont.)|July 25, 2025
The Impact of Adjuvant Chemotherapy on Clinical Outcomes in Locally Advanced Rectal Cancer: A CHORD Consortium AnalysisKaveh Farrokhi, Horia Marginean, Anas Al Ghamdi, et al.
Clinical & Experimental Metastasis|November 29, 2011
Stage-dependent differential expression of microRNAs in colorectal cancer: potential role as markers of metastatic diseaseMichael M Vickers, Jair Bar, Ivan Gorn-Hondermann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 3, 2025
Randomized Phase II Trial of Pazopanib Versus Placebo in Patients With Advanced Extrapancreatic Neuroendocrine Tumors (Alliance A021202)Emily K Bergsland, Susan Geyer, Timothy R Asmis, et al.
Current Oncology (Toronto, Ont.)|April 27, 2026
Eastern Canadian Gastrointestinal Cancer Consensus Conference 2025Arwa Ahmed, Stéphanie L Mercier, Ravi Ramjeesingh, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
BMC Cancer|July 7, 2019
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiationShaan Dudani, Horia Marginean, Patricia A Tang, et al.
Cancer Biology & Therapy|July 3, 2010
EGFR expression variance in paired colorectal cancer primary and metastatic tumorsNirit Yarom, Celia Marginean, Terence Moyana, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2008
Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trialsTimothy R Asmis, Keyue Ding, Lesley Seymour, et al.
The Oncologist|March 29, 2014
An open-label phase II study evaluating the safety and efficacy of ramucirumab combined with mFOLFOX-6 as first-line therapy for metastatic colorectal cancerRocio Garcia-Carbonero, Fernando Rivera, Joan Maurel, et al.
Current Oncology (Toronto, Ont.)|July 25, 2025
The Impact of Adjuvant Chemotherapy on Clinical Outcomes in Locally Advanced Rectal Cancer: A CHORD Consortium AnalysisKaveh Farrokhi, Horia Marginean, Anas Al Ghamdi, et al.
Clinical & Experimental Metastasis|November 29, 2011
Stage-dependent differential expression of microRNAs in colorectal cancer: potential role as markers of metastatic diseaseMichael M Vickers, Jair Bar, Ivan Gorn-Hondermann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 3, 2025
Randomized Phase II Trial of Pazopanib Versus Placebo in Patients With Advanced Extrapancreatic Neuroendocrine Tumors (Alliance A021202)Emily K Bergsland, Susan Geyer, Timothy R Asmis, et al.
Current Oncology (Toronto, Ont.)|April 27, 2026
Eastern Canadian Gastrointestinal Cancer Consensus Conference 2025Arwa Ahmed, Stéphanie L Mercier, Ravi Ramjeesingh, et al.
Pageof 2